Polpharma products are present in approximately 50 countries worldwide. 20% of the company’s turnover comes from its international operations; 60% from the sales of medical drugs and 40% from active pharmaceutical ingredients (APIs).

The most important markets for Polpharma are those of Central and Eastern Europe, because they provide the greatest possibility for sales growth. Aiming to become a regional leader, the company has developed its international structures. Polpharma has sale structures in Russia and its own representative offices in  Ukraine, Lithuania, Belarus, Kazakhstan, Azerbaijan and Uzbekistan.

Approximately 60% of the international sales of drugs are generated on the Russian market. Polpharma's APIs are primarily exported to North America and the European Union. The APIs are sold through direct business contacts or via agents. POLPHARMA is also present at the most important trade fairs; for example, it is a regular exhibitor at CPhI, which is the world’s largest exhibition for the pharmaceutical ingredients and intermediates.